Mirae Asset Global Investments
RANI icon

Mirae Asset Global Investments’s Rani Therapeutics RANI Stock Holding History

Mirae Asset Global Investments’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82K Sell
5,026
-62
-1% -$55 ﹤0.01% 1636
2026
Q1 		$3.74K Buy
5,088
+348
+7% +$445 ﹤0.01% 1538
2025
Q4 		$6.4K Buy
+4,740
New +$7.15K ﹤0.01% 1623

Other funds holding RANI

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WDL
Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mirae Asset Global Investments's RANI Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Rani Therapeutics (RANI) stake by 1.2% in Q2 2026, selling an estimated $55 and leaving 5,026 shares worth $3.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Mirae Asset Global Investments first reported a position in RANI in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.4K in Q4 2025. 13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Mirae Asset Global Investments held 5,026 shares of Rani Therapeutics worth $3.82K as of Q2 2026.
  • Mirae Asset Global Investments sold 62 Rani Therapeutics shares in Q2 2026, an estimated $55.
  • Rani Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1636 holding.
  • Mirae Asset Global Investments first reported a position in Rani Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Rani Therapeutics position peaked at $6.4K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.